Bangladesh vs Iceland: Previously treated cases tested for RR-/MDR-TB
Bangladesh
100.0%
in 2024
Iceland
100.0%
in 2022
Bangladesh rank
1st
Iceland rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bangladesh
- Iceland
How they compare
Bangladesh currently reports 100.0% against 100.0% in Iceland, a difference of 0.0%.
The two have swapped places 3 times across 5 shared years of data; in 2011 it was Bangladesh ahead.
Bangladesh ranks 1st and Iceland ranks 1st of 180 countries.
Iceland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 34.8% | 62.5% | 27.8% | Iceland |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bangladesh or Iceland?
- Bangladesh, at 100.0% against 100.0% in Iceland as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bangladesh and Iceland?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Iceland?
- 5 years are reported by both, from 2011 to 2022.
- How do Bangladesh and Iceland rank globally for previously treated cases tested for rr-/mdr-tb?
- Bangladesh ranks 1st and Iceland ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.